Ph.D. University of South Florida, Tampa 1978; M.S. University of South Florida 1976; Post-Doctoral University of Illinois at Urbana-Champaign 1979
HISTORICAL RECORD OF EXTRAMURAL GRANT SUPPORT OF DR. HOSMANE (1983-PRESENT)
(Unless otherwise indicated, Dr. Hosmane is the PI)
(41) National Institutes of Health (NIGMS, #1R01GM087738), Inhibition of HCV as an Opportunistic HIV Co-infection, 2008-2012
(40) American Heart Association (# AHA 0755372U), Artificial Blood Based on Hemoglobin Dendrimers, 2007-09
(39) North American Biologicals, Inc. (Nabi) , Ring-Expanded Nucleosides & Nucleotides, 1997-09
(38) National Institutes of Health (NIAID, #R21AI071802), Mechanistic Studies of Anti-HIV Activity, 2006-08
(37) Greenbaum Cancer Center, UMB, Novel Nucleoside Analogs as Cancer Chemotherapeutics, 2006-07
(36) National Institutes of Health (NIAID, #R01AI55452), “Fat” Nucleosides & Nucleotides, 2002-07
(35) Grace Chemical Co., Synthesis of Novel Thiophene Analogues for Artificial Membranes, 2004-05
(34) National Institutes of Health (NHLBI, #R01HL48632), Novel Org. Reagents for Biomed. Appls, 1999-03
(33) National Institutes of Health (NHLBI, #R01HL48632-S1), Res. Suppl. Minority Undergrad. Asst., 2000-02
(32) Transbio Corp., Synthesis of a Novel Heterocycle for Sensitive Detn. of Proteins & Nucl. Acids, 2001-01
(31) Novadaq Corp., Canada, Synthesis of Indocyanine Green for Surgery in Opthamology, 2001-01
(30) National Institutes of Health ((NCI, #R01 CA71079),“Fat” & “Slim” Nucleosides & Nucleotides, 1996-00
(29) National Institutes of Health ((NCI, #R01 CA71079-S1), Res. Suppl. Minority Undergrad. Asst.,1997-00
(28) Maryland Industrial Partnership (MIPS #910.19), Nucleosides for Antiviral Activity, 1997-99
(27) National Science Foundation (Whalen, P. I.), High Field NMR Inter. Data Anal. & Modeling, 1996-98
(26) National Institutes of Health (NHLBI, #R01 HL33629), Novel Org. Reagents for Biomed. Appl., 1994-97
(25) Maryland Industrial Partnerships (MIPS #813.18), Stable Photochromic Compounds, 1994-96
(24) National Institutes of Health (NIGMS, #R01 GM49249), Novel Antiretroviral Nucleo(s/t)ides, 1992-96
(23) Boehringer-Mannheim Corp., Novel Heterocycles as Potential Therapeutic Agents, 1991-96
(22) National Institutes of Health (NIGMS, #R01 GM49249), Res. Suppl. Minority Grad. Asst., 1992-95
(21) Maryland Industrial Partnerships (MIPS, #1307.13), Novel Nucleosides for AIDS Therapy, 1992-95
(20) Rhone-Poulenc, Novel Heterocycles as Potential Agricultural Chemicals, 1991-95
(19) Maryland Industrial Partnerships (MIPS, #2001.27), Hemoglobin Blood Substitutes, 1991-94
(18) Martin-Marietta Laboratories, Synthesis of Photochromes for Holograms & Sensor Protection , 1993-94
(17) Autodesk, Inc., Design & Synthesis of Novel Organic Molecules for Biomedical Applications, 1992-93
(16) Burns Laboratories, Inc., Altered Nucleoside with Potential for AIDS Therapy, 1991-1993
(15) Burns Laboratories, Inc., Human Hemoglobin Cross-Linking Reagents, 1991-93
(14) National Institutes of Health (P.I. G. Rosen, UMB), Synthesis of Heterocyclic Spin Labels, 1990-92
(13) National Institutes of Health (NCI, #1R01 CA36154), “Fat” Nucleosides & Nucleotides, 1987-91
(12) Dow-Elanco Co., Novel Organics for Agricultural and Biomedical Applications, 1987-91
(11) Am. Cancer Soc.(MD Progr.), Is There a Correln bet. Conformn. & Activity of Nucleo(s/t)ides?, 1989-90
(10) Cytel Corporation, Biological Screening of Potential Immune Modulating Agents, 1989-90
(09) Monsanto Agricultural Co., Novel Heterocycles for Potential Agricultural Applications, 1989-94
(08) E. I. du Pont de Nemours & Co., Novel Het. Compds. as Potential Agricultural Chemicals, 1988-96
(07) American Heart Assoc., MD Affiliate, Inc., Synthetic Reagents to Cross-Link Hemoglobin, 1987-89
(06) Eli Lilly & Co., Novel Compounds for Potential Medicinal & Agricultural Applications, 1986-1993.
(05) National Institutes of Health (NHLBI, E. Bucci, P.I.), Hemoglobin-Based Oxygen Carriers, 1985-88
(04) Shell Development Company, Novel Compounds for Potential Agricultural Applications, 1985-86
(03) National Institutes of Health (NCI, #R01 CA36154), Synthetic Analogues of Coformycin, 1984-87
(02) Project SEED, Am. Chem. Soc., Summer Educational Experience for the Disadvantaged, 1983-00.
(01) Petroleum Research Fund, American Chemical Society, Total Synthesis of Coformycin, 1983-85